# ArgenTAG

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/argentag

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.argentag.com
- Latest round: Seed (Feb 8, 2022)
- Investors on record: 1

## About

Based in New York, US, and founded in 2021, ArgenTAG Corporation operates as a biotech company that develops innovative genomic sequencing applications using proprietary technology. In February 2022, ArgenTAG raised seed funding from investor SOSV.

The company offers proprietary technology for long-read sequencing applications, including sequencing service, sequencing advisory, and sequencing kits.

## Funding rounds

- Seed, Feb 8, 2022 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed